Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
D'Antuono I
Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice
by rapid deesterification in animals and humans
Irbesartan
Edoxaban - CAS# 480449-70-5 somer D'Antuono IEdoxaban (INN, codenamed DU 176b, trade name Lixiana) is a potent, selective factor Xa inhibitor, which has good oral bioavailability. Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is being developed by Daiichi Sankyo. It was approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower limb orthopedic surgery. It was also approved by the FDA in January 2015 for the prevention of
US$ 70.00
US$ 48.00
US$ 56.00
US$ 72.00
US$ 58.00
US$ 72.00
US$ 98.00
US$ 75.00
US$ 150.00
US$ 180.00
US$ 85.00